Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseases Qfitlia, the first antithrombin-lowering therapy for hemophilia, can offer consistent protection with as few as six ...

Right now, more than 607,000 children, adults, and seniors in Central and Eastern North Carolina face uncertainty about where their next meal will come from. In the Southeastern region alone, 1 in 6 ...

Emerging markets, breakthrough technologies, and strategic M&A reshape competitive landscapeThe global molecular cytogenetics ...

All products featured on Self are independently selected by Self editors. However, when you buy something through our retail links, Condé Nast may earn an affiliate commission. When your car is low on ...